Position in ZYME
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$392,100
+$16,500 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#125
of 203 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $244,660,599 across 8 Biotechnology names. ZYME ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
125,481 | $116,417,507 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,971 | $103,305,434 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
66,941 | $12,536,710 | |
| 4 | RPRX |
Royalty Pharma plc
|
56,268 | $3,154,945 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,819 | $3,004,838 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
12,200 | $2,939,833 | |
| 7 | INSM |
INSMED Inc
|
27,286 | $2,909,232 | |
| 8 | ZYME |
Zymeworks Inc.
This page
|
15,000 | $392,100 |
All Filings in ZYME
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,100 | 15,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $375,600 | 15,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $394,950 | 15,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||